Balyasny Asset Management LLC Syros Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.69 - $1.21 $10,232 - $17,944
14,830 New
14,830 $14,000
Q2 2018

Aug 14, 2018
SELL
$10.16 - $13.65 $104,648 - $140,595
-10,300 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$9.47 - $12.98 $179,930 - $246,620
-19,000 Reduced 64.85%
10,300 $134,000
Q4 2017

Feb 14, 2018
BUY
$8.45 - $17.48 $247,584 - $512,164
29,300
29,300 $285,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.25M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email